Persistent URL of this record https://hdl.handle.net/1887/122624
In Collections
This item can be found in the following collections:
![Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
- All authors
- Teng, Y.K.O.; Bruce, I.N.; Diamond, B.; Furie, R.A.; Vollenhoven, R.F. van; Gordon, D.; Groark, J.; Henderson, R.B.; Oldham, M.; Tak, P.P.
- Date
- 2019-06-01
- Journal
- BMJ Open
- Volume
- 9
- Issue
- 3